An anonymous investor intercepted the following transcript

New Post Public Reply Private Reply Replies (1) Message Board
Mo
717
An anonymous investor intercepted the following transcript of the weekly Paid Basher conference call. The following is heavily encrypted to protect the paid basher’s identities but clearly states their talking points for the coming week. I haven’t yet vetted its authenticity.
=================================================
“This last week has been difficult with IPIX’s damn CEO surprising us once again with a PR of a Term sheet for what was supposed to be their second instance of Brilacidin. This was as much of a surprise to us as that damn European Subsidiary PR out of nowhere. We are upside down on this damn little stock and we need shares. Your job is to shake loose whatever shares you can get. Time is of the essence as there could be a PR out any day now that will name the Global Pharma and will blow away most of our false narratives of funding, dilution, management execution, science validation and market value. New investors will flood in and we will be F****ed! I realize that some of you have had a decrease in commissions with no one replying to your posts if you are on that damn Kelt’s “swindlers list”. We take care of our own so we will double your price per post from 10 to 20 cents. This should keep you in the upper echelon of income in your shithole countr….err remote locations. That damn Drano keeps taking down our posts where we flat out lie and attack long term investors. What kind of BS message board is this anyways? That 4kids poster I swear is from a different planet and has been tracking every move we make and now half the damn board is knows what we are doing. This week’s assignments are as follows:

trrol and FloppyhatCA- You two keep up on our secret Operation Toss Salad. Keep up the mouth to anus narrative, stop all that giggling, this is serious! The investors for some reason aren’t buying this narrative even though Wikipedia says so. These investors are actually reading the IPIX PR’s and we are so screwed if they kick off a phase3 for B-OM soon with ample funding from 1 or maybe 2 large license deals. Anyways keep pretending you have a zillion shares and turn up the FUD that no one is interested in B-OM or really anything IPIX has in their portfolio.

YellowfruitFeline – Continue to use your math skills. When someone talks about the market size divide by 3. When they talk license revenue divide by 3. When you end up with a number divide by 2 again. Take the lessor of that number or just use $1 or $2 per share best case. Tell them how lucky they would be to get a 4X from today’s SP. Remember we need some of these fools to put in GTC orders under $3 so that we can pick them off when this damn stock takes off. We need REAL shares!

JudasStockings- Just keep coming up with new aliases and see if any of them stick. Maybe a Doctor or Bio Chemist. Use your imagination and act insulted if they call you out. You can have a zillion shares as well but don’t get trapped into admitting who your past aliases were.

Whiny Operative- Continue to post that you are OK with dilution but cut and paste blather from the financials from the MFO funding and maybe some Aspire FUD. Ignore the fact that this company has minimal dilution entering into a phase 3. Flood the board and continue to make friends.

HeadLice/NoSurrender – Keep attacking the NSS exposers. Call NSS the bogeyman, and accuse the real investors of doing what we are doing. It doesn’t work very well but it really disrupts this stupid board with their rules and such.

The rest of you remember to turn up the heat. Lie, contradict, start arguments with real investors and even each other to disrupt this board. Reiterate how lucky these SOB’s will be if they can get out with a dollar or 2. Time is our enemy.”
1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading

Top 5 Most Recently Viewed Articles

SBVA Triumphs as Venture Capital Leader in Prestigious Award

Updated Category News Views 194

SBVA Achieves Prestigious Recognition SBVA, formerly known as SoftBank Ventures Asia, recently earned the esteemed title of "VC of the Year" at the annual Korea Venture Capital Awards. This significant honor highlights SBVA's remarkable investment performances and its vital role in enhancing the venture ecosystem. The Importance of the Korea Venture Capital Awards The...

Continue Reading
Strategic Acquisition: TopBuild Expands with Metro Supply Company

Updated Category News Views 116

Strategic Acquisition by TopBuild TopBuild Corp. (NYSE:BLD), a leader in insulation installation and specialty distribution for the construction sector, has recently made a significant move by agreeing to acquire Metro Supply Company. This acquisition is set to enhance TopBuild’s offerings in the commercial and industrial insulation market and is expected to bring in...

Continue Reading
Key Class Action Update on MoonLake Immunotherapeutics (MLTX)

Updated Category News Views 117

MoonLake Immunotherapeutics Faces Class Action Lawsuit Investors should be aware that MoonLake Immunotherapeutics (NASDAQ: MLTX) is currently facing a class action lawsuit due to alleged violations of securities laws. The DJS Law Group is actively reminding shareholders of their rights in light of this legal action, emphasizing the importance of staying informed during...

Continue Reading
Columbus McKinnon Set to Shine at Global Industrial Conference

Updated Category News Views 119

Columbus McKinnon Corporation's Participation in a Key Event Columbus McKinnon Corporation (Nasdaq: CMCO), a prominent name in the design and manufacturing of motion solutions, is excited to announce its participation in an upcoming event that is significant for the industry. The company will showcase its expertise at the Baird Global Industrial Conference. This important...

Continue Reading
The Growth of a $100 Investment in Norfolk Southern Over 20 Years

Updated Category News Views 64

The Benefits of Long-Term Investments in Norfolk Southern Investing wisely can truly change your financial landscape, and Norfolk Southern (NYSE: NSC) is a stellar example of this. Over the last 20 years, investing in NSC has yielded remarkable results, achieving an annualized growth rate of 5.31%. This outstanding performance has led to an impressive average annual...

Continue Reading